^
Association details:
| Biomarker: | CA9 overexpression |
|---|---|
| Cancer: | Neuroendocrine Tumor |
| Drug: | doxorubicin hydrochloride (Topoisomerase II inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors
Excerpt:
...19 received doxorubicin...Mean high expression of the following predicted a lack of response to the following cytotoxics (Table 2)...doxorubicin, Ki-67 (P=0.05)...and CA9 (P=0.02)....These results demonstrate a number of new prognostic biomarkers in GEP-NET, and in addition, response to chemotherapy was correlated ...
DOI:
10.1677/ERC-09-0204
